Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients [1]

Journal of Hepatology

Volumn 32, Issue 6, 2000, Pages 1040-1041

  Van Nunen, A B ^a   De Man, R A ^a   Heijtink, R A ^a   Niesters, H G M ^a   Schalm, S W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; NUCLEOSIDE ANALOG; VIRUS DNA;

CHRONIC HEPATITIS; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LETTER; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; VIREMIA; VIRUS REPLICATION;

EID: 0034083125     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80112-9     Document Type: Editorial

References (5)

1. HMH Ip PN Lelie VCW Wong MC Kuhns HW Reesink Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA Lancet i 1989 406 410
2. SL Ngui NJ Andrews GS Underhill J Heptonstall CG Teo Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors Clin Infect Dis 27 1998 100 106
3. R del Canho PM Grosheide JA Mazel RA Heijtink WCJ Hop LJ Gerards Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity Vaccine 15 1997 1624 1630
4. LM Mofenson Short-course zidovudine for prevention of perinatal infection Lancet 353 1999 766 767
5. J Moodley D Moodley K Pillay H Coovadia J Saba R van Leeuwen Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring J Infect Dis 178 1998 1327 1333